Evidence map›Paper›PMID 31525954›Full record

ArticleACS nano2019

Corona Composition Can Affect the Mechanisms Cells Use to Internalize Nanoparticles.

Valentina Francia, Keni Yang, Sarah Deville, Catharina Reker-Smit, Inge Nelissen, Anna Salvati

Open access · hybridAbstract read
In one paragraph

Article in ACS nano, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 114 papers.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed
14.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 279 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Perfluorocarbon-Loaded Poly(lactide-ACS applied polymer materials · 2025
    Article
  18. Article
  19. Article
  20. Article

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Valentina FranciaDepartment of Pharmacokinetics, Toxicology and Targeting, Groningen Research Institute of Pharmacy , University of Groningen , Antonius Deusinglaan 1 , 9713AV Groningen , The Netherlands.ORCID 0000-0003-4911-6832
Keni YangDepartment of Pharmacokinetics, Toxicology and Targeting, Groningen Research Institute of Pharmacy , University of Groningen , Antonius Deusinglaan 1 , 9713AV Groningen , The Netherlands.
Sarah DevilleHealth Department , Flemish Institute for Technological Research (VITO) , Boeretang 200 , 2400 Mol , Belgium.ORCID 0000-0002-5615-8603
Catharina Reker-SmitDepartment of Pharmacokinetics, Toxicology and Targeting, Groningen Research Institute of Pharmacy , University of Groningen , Antonius Deusinglaan 1 , 9713AV Groningen , The Netherlands.
Inge NelissenHealth Department , Flemish Institute for Technological Research (VITO) , Boeretang 200 , 2400 Mol , Belgium.
Anna SalvatiDepartment of Pharmacokinetics, Toxicology and Targeting, Groningen Research Institute of Pharmacy , University of Groningen , Antonius Deusinglaan 1 , 9713AV Groningen , The Netherlands.ORCID 0000-0002-9339-0161
University of Groningen · NLFlemish Institute for Technological Research · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanosized objects, such as nanoparticles and other drug carriers used in nanomedicine, once in contact with biological environments are modified by adsorption of biomolecules on their surface. The presence of this corona strongly affects the following interactions at cell and organism levels. It has been shown that corona proteins can be recognized by cell receptors. However, it is not known whether the composition of this acquired layer can also affect the mechanisms nanoparticles use to enter cells. This is of particular importance when considering that the same nanoparticles can form different coronas for instance

Indexed as

NanomedicineAdsorptionDrug Administration RoutesDrug CarriersHeLa CellsHumansLiposomesNanoparticlesProtein CoronaSilicon DioxideSurface PropertiesDrug CarriersLiposomesProtein CoronaSilicon Dioxidebiomolecule coronananoparticlesilicatransport inhibitorsuptake mechanisms

Identifiers

PMID31525954
PMCPMC6812477
OpenAlexW2974386912

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.